ArticleMolecular biology and evolution2026
Evolutionary trajectories, early diversification, and species-specific amplification of the metazoan inhibitor of apoptosis (IAP) repertoire.
Article in Molecular biology and evolution, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
IAP proteins play central roles in regulating apoptosis and diverse cellular processes, influencing cancer biology, or stress resistance in economically important species, highlighting their major biomedical and ecological relevance. Despite this importance, IAP evolutionary diversity and history remain largely unexplored. Here, we present a large-scale comparative analysis of 2,843 IAP proteins from 312 species spanning all major animal lineages, revealing striking variation in IAP repertoire size and exceptional architectural diversity. We show that IAP expansion has repeatedly emerged through lineage-specific duplication events, seemingly shaped by different duplication dynamics with more recent gene family expansions in arthropods compared with mollusks and chordates. Expression data show that IAP expansion supports distinct strategies. Bivalves and gastropods mobilize multiple IAP subfamilies in response to biotic and abiotic stress, whereas aphids exhibit differential IAP expression associated with polyphenism. These contrasting patterns indicate that heterogeneous selective pressures have recurrently reshaped IAP repertoires, promoting lineage- and species-specific functional diversification. Despite this diversification, phylogenetic analyses reveal the maintenance of a core set of three IAP types. Survivin/Deterin-like and Bruce-like IAPs emerged early in metazoans and remained structurally conserved, although Bruce-like IAPs were independently lost in chelicerates, most nematodes, and some hemipteran insects. RING-containing IAPs also originated early but followed more dynamic evolutionary trajectories, being lost in nematodes and platyhelminthes while expanding in other lineages through domain acquisition (eg gnathostomes) or repeated domain duplication and loss (eg mollusks and insects). Our findings establish a comprehensive evolutionary framework for metazoan IAPs, linking lineage-specific diversification to structural innovation and functional specialization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.